95 related articles for article (PubMed ID: 12048901)
1. Effects of carvedilol on plasma levels of interleukin-6 and tumor necrosis factor-alpha in nine patients with dilated cardiomyopathy.
Matsumura T; Tsushima K; Ohtaki E; Misu K; Tohbaru T; Asano R; Nagayama M; Kitahara K; Umemura J; Sumiyoshi T; Hosoda S
J Cardiol; 2002 May; 39(5):253-7. PubMed ID: 12048901
[TBL] [Abstract][Full Text] [Related]
2. A controlled study of the effects of carvedilol on clinical events, left ventricular function and proinflammatory cytokines levels in patients with dilated cardiomyopathy.
Tatli E; Kurum T
Can J Cardiol; 2005 Mar; 21(4):344-8. PubMed ID: 15838561
[TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol on plasma levels of pro-inflammatory cytokines in patients with ischemic and nonischemic dilated cardiomyopathy.
Kurum T; Tatli E; Yuksel M
Tex Heart Inst J; 2007; 34(1):52-9. PubMed ID: 17420794
[TBL] [Abstract][Full Text] [Related]
4. Concentration of BNP, endothelin 1, pro-inflammatory cytokines (TNF-alpha, IL-6) and exercise capacity in patients with heart failure treated with carvedilol.
Nessler J; Nessler B; Kitliński M; Gackowski A; Piwowarska W; Stepniewski M
Kardiol Pol; 2008 Feb; 66(2):144-51; discussion 152-3. PubMed ID: 18344152
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy.
Ohtsuka T; Hamada M; Saeki H; Ogimoto A; Hiasa Go; Hara Y; Shigematsu Y; Hiwada K
Am J Cardiol; 2002 Apr; 89(8):996-9. PubMed ID: 11950447
[No Abstract] [Full Text] [Related]
6. Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.
Cinquegrana G; D'Aniello L; Landi M; Spinelli L; Grande G; De Prisco F; Petretta M
J Card Fail; 2005 Apr; 11(3):213-9. PubMed ID: 15812750
[TBL] [Abstract][Full Text] [Related]
7. Arg389Gly-beta1-adrenergic receptors determine improvement in left ventricular systolic function in nonischemic cardiomyopathy patients with heart failure after chronic treatment with carvedilol.
Chen L; Meyers D; Javorsky G; Burstow D; Lolekha P; Lucas M; Semmler AB; Savarimuthu SM; Fong KM; Yang IA; Atherton J; Galbraith AJ; Parsonage WA; Molenaar P
Pharmacogenet Genomics; 2007 Nov; 17(11):941-9. PubMed ID: 18075464
[TBL] [Abstract][Full Text] [Related]
8. Carvedilol in children with cardiomyopathy: 3-year experience at a single institution.
Rusconi P; Gómez-Marín O; Rossique-González M; Redha E; Marín JR; Lon-Young M; Wolff GS
J Heart Lung Transplant; 2004 Jul; 23(7):832-8. PubMed ID: 15261177
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of carvedilol in infants with dilated cardiomyopathy: a preliminary report.
Gachara N; Prabhakaran S; Srinivas S; Farzana F; Krishnan U; Shah MJ
Indian Heart J; 2001; 53(1):74-8. PubMed ID: 11456146
[TBL] [Abstract][Full Text] [Related]
10. Carvedilol therapy in pediatric patients with dilated cardiomyopathy.
Askari H; Semizel E; Bostan OM; Cil E
Turk J Pediatr; 2009; 51(1):22-7. PubMed ID: 19378887
[TBL] [Abstract][Full Text] [Related]
11. Impact of initiating carvedilol before angiotensin-converting enzyme inhibitor therapy on cardiac function in newly diagnosed heart failure.
Sliwa K; Norton GR; Kone N; Candy G; Kachope J; Woodiwiss AJ; Libhaber C; Sareli P; Essop R
J Am Coll Cardiol; 2004 Nov; 44(9):1825-30. PubMed ID: 15519014
[TBL] [Abstract][Full Text] [Related]
12. Effects of carvedilol on right ventricular ejection fraction and cytokines levels in patients with systolic heart failure.
Tatli E; Kurum T; Aktoz M; Buyuklu M
Int J Cardiol; 2008 Apr; 125(2):273-6. PubMed ID: 18053592
[TBL] [Abstract][Full Text] [Related]
13. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment.
Kawai K; Hata K; Takaoka H; Kawai H; Yokoyama M
Am Heart J; 2001 Jun; 141(6):925-32. PubMed ID: 11376305
[TBL] [Abstract][Full Text] [Related]
14. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
[TBL] [Abstract][Full Text] [Related]
16. Effects of carvedilol, a vasodilator-beta-blocker, in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group.
Circulation; 1995 Jul; 92(2):212-8. PubMed ID: 7600653
[TBL] [Abstract][Full Text] [Related]
17. Serum levels of matrix metalloproteinases and tumor necrosis factor-alpha in patients with idiopathic dilated cardiomyopathy and effect of carvedilol on these levels.
Ohtsuka T; Hamada M; Saeki H; Ogimoto A; Hara Y; Shigematsu Y; Higaki J
Am J Cardiol; 2003 Apr; 91(8):1024-7, A8. PubMed ID: 12686357
[No Abstract] [Full Text] [Related]
18. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
19. Carvedilol reverses elevated pulmonary vascular resistance in a child with dilated cardiomyopathy.
Horenstein MS; Ross RD; Singh TP; Epstein ML
Pediatr Cardiol; 2002; 23(1):100-2. PubMed ID: 11922497
[TBL] [Abstract][Full Text] [Related]
20. Comparison of circulating levels of interleukin-6 and tumor necrosis factor-alpha in hypertrophic cardiomyopathy and in idiopathic dilated cardiomyopathy.
Högye M; Mándi Y; Csanády M; Sepp R; Buzás K
Am J Cardiol; 2004 Jul; 94(2):249-51. PubMed ID: 15246916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
